Adaptive Biotechnologies Corporation
ADPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$159,595 | -$225,250 | -$200,191 | -$207,279 |
| Dep. & Amort. | $19,256 | $22,231 | $28,147 | $20,981 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $53,610 | $0 | $0 | $0 |
| Change in WC | -$17,454 | -$46,183 | -$71,546 | -$56,816 |
| Other Non-Cash | $8,971 | $92,878 | $59,645 | $50,387 |
| Operating Cash Flow | -$95,212 | -$156,324 | -$183,945 | -$192,727 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,664 | -$10,697 | -$16,349 | -$61,746 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$244,257 | -$429,558 | -$278,778 | -$316,544 |
| Inv. Sales/Matur. | $325,713 | $569,902 | $298,032 | $559,500 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $77,792 | $129,647 | $2,905 | $181,210 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $124,375 | $0 |
| Stock Issued | $241 | $2,245 | $7,890 | $26,717 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $429 |
| Financing Cash Flow | $241 | $2,245 | $132,265 | $27,146 |
| Forex Effect | $0 | -$534 | -$260 | $0 |
| Net Chg. in Cash | -$17,179 | -$24,966 | -$49,035 | $15,629 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $67,996 | $90,030 | $139,065 | $123,436 |
| End Cash | $50,817 | $65,064 | $90,030 | $139,065 |
| Free Cash Flow | -$98,876 | -$167,021 | -$200,294 | -$254,473 |